top of page

22Rv1 Xenograft Model

Rincon Bio offers efficacy studies using the 22Rv1 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Prostate
Derivation:
Primary prostate carcinoma of an adult male
Mutations:
KMT2D, PIK3CA, TP53
NCI60:
No
Weeks from stratification to termination (average):
5

22Rv1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the 22Rv1 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page